Trial of ePAL digital therapeutic app associated with lower pain and pain-related hospitalizations in patients with advanced cancer.

A randomized controlled trial evaluated the effectiveness of the ePAL digital therapeutic app in managing pain for patients with advanced cancer receiving care in a specialty palliative care clinic at a tertiary care hospital. The study found that patients using ePAL reported lower pain scores compared to those receiving usual care. Additionally, ePAL users had fewer pain-related hospitalizations.

Authors concluded the study demonstrates the potential of digital therapeutics for improving patients' symptoms and reducing hospitalizations.

Read the study

Get the latest updates in your inbox!